Belgium – Antineoplastic and immunomodulating agents – Raamovereenkomst voor de aankoop van Infliximab voor intraveneuze toediening

This is an open tender for a 12-month framework agreement for the supply of Infliximab for intravenous administration, issued by Ziekenhuis aan de Stroom vzw (ZAS), a hospital in Antwerp, Belgium. The contract value is estimated at EUR 2,300,000 with a framework maximum of EUR 3,320,000. Submission deadline is 2026-07-01 10:00 (CEST). The tender is in Dutch, electronic submission is required, and award is based on quality (40%) and price (60%). Only one lot is identified in the notice, despite structured data indicating multiple lots.